Evidence map›Paper›PMID 22820548›Full record

ArticleBiochimica et biophysica acta2012

GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation.

Maria Negahdar, Ingvild Aukrust, Bente B Johansson, Janne Molnes, Anders Molven, Franz M Matschinsky, Oddmund Søvik, Rohit N Kulkarni, Torgeir Flatmark, Pål Rasmus Njølstad and 1 more

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Case 6-2020: A 34-Year-Old Woman with Hyperglycemia.The New England journal of medicine · 2020
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Maria NegahdarDepartment of Clinical Medicine, University of Bergen, N-5020 Bergen, Norway.
Ingvild Aukrust
Bente B Johansson
Janne Molnes
Anders Molven
Franz M Matschinsky
Oddmund Søvik
Rohit N Kulkarni
Torgeir Flatmark
Pål Rasmus Njølstad
Lise Bjørkhaug
Haukeland University Hospital · NOJoslin Diabetes Center · USUniversity of Bergen · NOUniversity of Pennsylvania · US

Funding

Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
INSULIN &GLUCOSE SIGNALING PATHWAYS IN ISLET BETA CELLSK08DK002885 · NIDDK · JOSLIN DIABETES CENTER · PI KULKARNI, ROHIT N. · 2000 to 2004
$540k
NIDDK NIH HHS K08 DK002885NIDDK NIH HHS R01 DK067536
6 · The paper itself

Abstract

GCK-MODY, dominantly inherited mild fasting hyperglycemia, has been associated with >600 different mutations in the glucokinase (GK)-encoding gene (GCK). When expressed as recombinant pancreatic proteins, some mutations result in enzymes with normal/near-normal catalytic properties. The molecular mechanism(s) of GCK-MODY due to these mutations has remained elusive. Here, we aimed to explore the molecular mechanisms for two such catalytically 'normal' GCK mutations (S263P and G264S) in the F260-L270 loop of GK. When stably overexpressed in HEK293 cells and MIN6 β-cells, the S263P- and G264S-encoded mutations generated misfolded proteins with an increased rate of degradation (S263P>G264S) by the protein quality control machinery, and a propensity to self-associate (G264S>S263P) and form dimers (SDS resistant) and aggregates (partly Triton X-100 insoluble), as determined by pulse-chase experiments and subcellular fractionation. Thus, the GCK-MODY mutations S263P and G264S lead to protein misfolding causing destabilization, cellular dimerization/aggregation and enhanced rate of degradation. In silico predicted conformational changes of the F260-L270 loop structure are considered to mediate the dimerization of both mutant proteins by a domain swapping mechanism. Thus, similar properties may represent the molecular mechanisms for additional unexplained GCK-MODY mutations, and may also contribute to the disease mechanism in other previously characterized GCK-MODY inactivating mutations.

Indexed as

GlucokinaseMutant ProteinsProteostasis DeficienciesDiabetes Mellitus, Type 2HEK293 CellsHumansMutationOctoxynolProtein ConformationProtein FoldingProtein MultimerizationProteolysisReticulocytesGlucokinaseMutant ProteinsOctoxynol

Identifiers

PMID22820548
PMCPMC3444650
OpenAlexW1990961501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.